Wednesday, 1 December 2021

Australia's most trusted
source of pharma news

Wednesday, 1 December 2021
Hunt to quit? Rumours intensify

Speculation that Health Minister Greg Hunt will retire from politics has reached a frenzy, with rumours naming the day he intends to quit.

Big names for HTA Review
Two companies selected to help get review underway
Top 10 most expensive drugs
Drugs ranked by greatest cost to government in 2020-21
Patent loss bites BMS hard
Loss of exclusivity on cancer drug to cost millions
Who'll be a good leader in 2022?
New style of leadership exposes must-have skills for those at the top
30 November
Staff drive workplace change
Workers' priorities shift and companies need to keep up
29 November
Gongs for best in med affairs
Meet the two winners of APPA's 2021 Excellence Awards
29 November
Top exec wins two promotions
Back-to-back career wins sees leader move up the ranks
26 November
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (4)

Sales & Customer Relations (37)

Clinical & Medical, R&D (25)

Regulatory, Pharmacovigilance & QA (8)

Other (22)

Covid wars: Pfizer vs MSD
MSD hits a speed bump while Pfizer boosts production
Cancer deaths strike new low
Report predicts how many Aussies will die of cancer in 2021
Blast off for Aussie mRNA vax
450 doses of first local Covid mRNA vaccine ready for human study
30 November
MA agreement branded 'sexy'
Parliamentary debate delivers unusual view on deal with government
30 November
CEO: mRNA turf war must end
BioCina calls for truce as company opens Aussie manufacturing facility
30 November
Alzheimer's in the spotlight
Biogen backed report calls for National Framework to manage the disease
30 November
New contraceptive wins thumbs up
The first novel hormone OCP available in Australia, in a decade
30 November
Omicron kicks off new vax race
Claims of three months to develop new variant vaccines put to the test
29 November
Hunt: will he stay or will he go?
Plus who's unveiled glowing admiration for the Health Minister?
29 November
Speedy PBS win for new path
Dec listing shows early re-entry can accelerate access
29 November
'Patient-centric? I don't think so'
Rare Cancers Australia call out the buzzwords that mask real experience
26 November
Big week for diabetes drugs
Bayer's drug ticked plus generic registered for MSD blockbuster
29 November APPROVALS
Patients call for Cancer Code
Ensuring the rights of Aussie patients are upheld
26 November
Zimmerman's access revolution
Radical overhaul of Australia's health system to fast-track access
25 November
pif 20K
pif 20K
Welcome to Pharma in Focus

Please log in to read.


Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.


Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).


You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.


You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.